Attovia Therapeutics, Inc. (ATTO) vs Anteris Technologies Global Corp. (AVR)
A side-by-side comparison of Attovia Therapeutics, Inc. and Anteris Technologies Global Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$18.00HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
AVR
Anteris Technologies Global Corp.
$7.10HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — ATTO vs AVR
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)AVR -6.2% (-6.2%/yr)AVR compounded faster over this window
ATTO AVR
ATTO vs AVR: by the numbers
- •ATTO is the larger company ($775M vs $690M market cap).
- •Both run net losses; ATTO's is the smaller (-4490.89% vs -4619.67% net margin).
Metrics side by side
Valuation
| Metric | ATTO | AVR |
|---|---|---|
| P/S ratio | N/A | 307.92 |
| P/B ratio | N/A | 2.75 |
Profitability
| Metric | ATTO | AVR |
|---|---|---|
| Gross margin | 40.44% | -16.57% |
| Operating margin | -4974.74% | -4908.21% |
| Net margin | -4490.89% | -4619.67% |
| ROE | -40.21% | -41.20% |
| ROIC | -42.83% | -41.63% |
Growth (annualized)
| Metric | ATTO | AVR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -18.92% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.